Growth Metrics

Whitehawk Therapeutics (WHWK) Current Deferred Revenue (2018)

Whitehawk Therapeutics (WHWK) has disclosed Current Deferred Revenue for 1 consecutive years, with $18.7 million as the latest value for Q2 2018.